← Mechanisms of action
SARS-CoV-2
ORGANISMSevere acute respiratory syndrome coronavirus 2
Drugs acting on this target (199)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| sicov/kk46 | Antisense inhibitor | experimental | Nucleic acid | SARS-CoV-2 antisense inhibitor |
| 202-cov | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| a vaccine composed of a recombinant s1 antigen | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| aahi-sc2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| abncov2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| abo-cov.617.2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| acm-001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ad5-tricov/mac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| adc vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| adcld-cov19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| adcovid | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| adimrsc-2f | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ag0301-covid19 | Immunity, active | experimental | Biological | SARS-CoV-2 immunity, active |
| aks-452 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| arct-021 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| arct-154 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| arct-165 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| av-covid-19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| avacc 10 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| b.1.351 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| b.1.617.2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bactrl-spike | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bbibp-corv | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bbv154 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bcd-250 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| betuvax-cov-2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bibp omicron inactivated covid-19 vaccine (vero cell) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bimervax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bivalent recombinant covid-19 vaccine (adenovirus type 5 vector) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| bsam2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chad-tricov/mac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chadox1 n-cov vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chadox1 ncov-19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chadv68-s | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chadv68-s-tce | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| chulacov19 mrna vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| coh04s1 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| coronavac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| corvax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cov2 sam | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cov2-ogen1 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covac-2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| Covaxin | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covend24 | Immunity, active | experimental | Biological | SARS-CoV-2 immunity, active |
| COVEPIT | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covi vax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covi-vac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covid-19 mrna vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covid-19 specific t cell derived exosomes | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covid-19 vaccine (vero cells) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covid-19 vaccine hipra | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| COVID-19 Vaccine, Adjuvanted (Nuvaxoid) | Immunity, active | approved | Vaccine | SARS-CoV-2 immunity, active |
| covid-19/aapc vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covid-evax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covidity | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covigen | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covishield | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| CoviVac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| covlp | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cv0501 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cv2cov | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cvncov vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| cvxga1 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| d614 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| dac-30 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| delns1-2019-ncov-rbd-opt1 (Pneucolin) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| delns1-ncov-rbd laiv | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| doco-pro-rbd-1 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ds-5670a | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| eg-covid-001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| eg-covid-003 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| egyvax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| epivaccorona | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| erucov-vac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| eucorvac-19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| exg-5003 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| gam-covid-vac lyo | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| gbp510 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| glb-cov2-043 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| gls-5130 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| gls-5310 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| grad-cov2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| grt-r910 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| grt-r918 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| gx-19 | Immunity, active | experimental | Biological | SARS-CoV-2 immunity, active |
| had5-s-fusion+n-etsd vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| hcvax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| hdt-301 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| iibr-100 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| in-b009 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| in01 vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| inactivated covid-19 vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| inactivated SARS-Cov-2 vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ino-4800 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| kbp-covid-19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| lnp-ncov sarna-02 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| lv-smenp-dc vaccine and antigen-specific ctls | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| lvrna009 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| lyb001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| MCTI-CIMATEC-HDT RNA | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mcv covid-19 vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mrna na vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mrna-1073 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mrna-1230 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mRNA-1283 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mt-2766 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mv-014-212 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mva-pp | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| mva-sars-2-s vaccinations | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| nanocovax | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| nbp2001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ndv-hxp-s | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| nvsi-06-08 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| omicron covid-19 vaccine (vero cell), inactivated | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| pasocovac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| pepgnp-covid19 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| pepgnp-sarscov2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| phh-1v81 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| pika covid-19 vaccine (cho cell, s-protein) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| prime-2-cov_beta | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ptx-covid19-b | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| qazcovid-in | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| qniv nanoparticle vaccine2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| recombinant covid-19 vaccine (sf9 cells) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| recombinant ndv vectored vaccine for sars-cov-2 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| recombinant novel coronavirus vaccine (adenovirus type 5 vector) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| recombinant sars-cov-2 vaccine (sf9 cell) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| rq3013 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| rvm-v001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| s-268019-b | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| s.opt.fl covid-19 pdna vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sam-lnp-s-tce | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov-2 ad5 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov-2 dna vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov-2 rs | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov-2 sclamp vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov-2 vlp vaccine - Turkey | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sars-cov-2 vlp vaccine-alpha (british) variant - Turkey | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sc-ad6-1 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| scb-2019 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| scb-2020s | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| scb-420 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sctv01c | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sii bivalent | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sinopharm vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| spfn_1b-06-pl | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| subunit recombinant vaccine for the prevention of coronavirus infection | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| sw-bic-213 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| tak-919 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| tmv-083 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| trivalent covid-19 vaccine (vero cell), inactivated, prototype strain, delta strain and omicron strain | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| turcovac | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| two-component covid-19 vaccine (cho cell) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| ub-612 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v-01 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v-01-351 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v-01-b5 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v-01d-351 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v3-x vaccine | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v590 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| v591 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| VAW00001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vaxzevria | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vb10.2129 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vb10.2210 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vbi-2901a | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vbi-2902a | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vbi-2905a | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vla2001 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| vxa-cov2-1 | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| zf2001 (Zifivax) | Immunity, active | experimental | Vaccine | SARS-CoV-2 immunity, active |
| acov2 | Immunity, passive | experimental | Vaccine | SARS-CoV-2 immunity, passive |
| ad 452 | Immunity, passive | experimental | Small molecule | SARS-CoV-2 immunity, passive |
| coronavirus-specific t cell (cst) | Immunity, passive | experimental | Cell therapy | SARS-CoV-2 immunity, passive |
| covid 19 immune globulin | Immunity, passive | experimental | Biological | SARS-CoV-2 immunity, passive |
| COVID-19 convalescent plasma | Immunity, passive | experimental | Biological | SARS-CoV-2 immunity, passive |
| covid-19 cytotoxic t lymphocytes | Immunity, passive | experimental | Cell therapy | SARS-CoV-2 immunity, passive |
| covid-19 t memory cells and nk cells | Immunity, passive | experimental | Cell therapy | SARS-CoV-2 immunity, passive |
| covid-higiv | Immunity, passive | experimental | Biological | SARS-CoV-2 immunity, passive |
| equine covid-19 antiserum | Immunity, passive | experimental | Animal product | SARS-CoV-2 immunity, passive |
| gc5131 | Immunity, passive | experimental | Biological | SARS-CoV-2 immunity, passive |
| inm005 | Immunity, passive | experimental | Animal product | SARS-CoV-2 immunity, passive |
| inosars | Immunity, passive | experimental | Animal product | SARS-CoV-2 immunity, passive |
| mtx-covab36 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| sab-185 | Immunity, passive | experimental | Biological | SARS-CoV-2 immunity, passive |
| sars-cov-2 equine immunoglobulin | Immunity, passive | experimental | Animal product | SARS-CoV-2 immunity, passive |
| sars-cov-2 hyperimmune globulin | Immunity, passive | experimental | Biological | SARS-CoV-2 immunity, passive |
| sars-cov-2 specific t cells | Immunity, passive | experimental | Cell therapy | SARS-CoV-2 immunity, passive |
| sars-cov2-ctls | Immunity, passive | experimental | Cell therapy | SARS-CoV-2 immunity, passive |
| ybsw015 | Immunity, passive | experimental | mAb | SARS-CoV-2 immunity, passive |
| abbv-990 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| asc10 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| edp-788 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| jt-001 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| Leritrelvir | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| pro-156 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |
| rv299 | Inhibitor | experimental | Small molecule | SARS-CoV-2 inhibitor |